重庆地区28家医院2004～2007年调脂药利用分析

Utilization of Antihyperlipidemics in 28 Hospitals of Chongqing from 2004 to 2007

目的:评估重庆地区调脂药的应用情况及趋势。方法:对重庆地区28家医院2004～2007年调脂药的销售金额、用药频度、日均费用等进行统计、分析。结果:该地区调脂药销售金额年增长率达33.80%以上。辛伐他汀销售金额和用药频度4年来一直位居前列,阿托伐他汀钙销售金额逐年快速增长,吉非贝齐逐年降低,年均递减60%。结论:他汀类药占重庆地区调脂药市场的主导地位,市场前景广阔。

OBJECTIVE： To evaluate the status and tendency of the application of antihyperlipidemics drugs in Chongqing area. METHODS： The use of antihyperlipidemics drugs in 28 hospitals of Chongqing from 2004 to 2007 was analyzed statisti- cally in respect of the consumption sum, DDDs and DDC. RESULTS： The mean annual incremental ratio of the consumption sum of antihyperlipidemics drugs reached over 33.80%. Simvastatin has been dominated the first place over the 4 years in terms of consumption sum and DDDs; the consumption sum of atorvastatin has been on the rise but that of Gemfibrozil decreased year on year with mean annual decrement of 60%. CONCLUSION： Statins assumed a dominant position among all the antihyper- lipidemics drugs used in Chongqing area and its use has great potential.